Vitamin D and hyperparathyroidism in obesity. - Wikidata - awgldk - TriplyDB

Vitamin D and hyperparathyroidism in obesity.

Vitamin D and hyperparathyroidism in obesity.

http://www.wikidata.org/entity/Q35468562

about

Role of Vitamin D in Osteoarthritis: Molecular, Cellular, and Clinical Perspectives Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels.Vitamin d and its relationship with obesity and muscle.Divergent effects of obesity on fragility fractures.Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa Vitamin D status is inversely associated with obesity in a clinic-based sample in Puerto Rico.Determinants of Secondary Hyperparathyroidism in Bariatric Patients after Roux-en-Y Gastric Bypass or Sleeve Gastrectomy: A Pilot Study.Bone Remodeling and Energy Metabolism: New Perspectives.Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study.Bariatric surgery results in cortical bone loss.Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients.Biochemical Assessment of Bone Health in Working Obese Egyptian Females with Metabolic Syndrome; the Effect of Weight Loss by Natural Dietary Therapies.Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study.Adiposity in the Relationship between Serum Vitamin D Level and Insulin Resistance in Middle-Aged and Elderly Korean Adults: The Korea National Health and Nutrition Examination Survey 2008 Vitamin D concentrations in familial combined hyperlipidemia: effects of lipid lowering treatment.Obesity and bone.Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension.Review article: The nutritional and pharmacological consequences of obesity surgery.Glycated hemoglobin A1C and vitamin D and their association with diabetic retinopathy severity.Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis.Is there any correlation between vitamin D insufficiency and diabetic retinopathy?Slipped upper femoral epiphysis: Outcome after in situ fixation and capital realignment technique.25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese.Higher circulating parathormone is associated with smaller and weaker bones in obese children.Serum vitamin D increases with weight loss in obese subjects 6 months after Roux-en-Y gastric bypass.Relationships of serum 25-hydroxyvitamin D, ionized calcium and parathyroid hormone after obesity surgery.Vitamin D levels in a paediatric population of normal weight and obese subjects.Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial.Predictive Factors of Secondary Normocalcemic Hyperparathyroidism after Roux-en-Y Gastric Bypass.Markers of Bone Metabolism in Obese Individuals Undergoing Laparoscopic Sleeve Gastrectomy.Thin bones: Vitamin D and calcium handling after bariatric surgery.Effect of Vitamin D Supplementation on Weight Loss, Glycemic Indices, and Lipid Profile in Obese and Overweight Women: A Clinical Trial Study

P2860

Q26801097-57E56AE0-1BA6-42D4-AF82-DB60F8562541 Q33964762-EB9E3DA9-B71C-4AC6-99C1-5FE5230DB39C Q34069006-6BDAB40E-EDB5-4FF0-94A3-923C76A9CEED Q34273341-483AFB45-F521-4E33-A857-BA29A9F5A91A Q34571243-216B9D56-120C-49D9-BF19-594416B8D598 Q34676274-E99E68A5-077D-4FF8-8584-F9584D5FFB99 Q35224332-1DB0127E-2336-49D0-9899-0BE857256C73 Q35534564-06B5A736-0522-47EC-A5D9-0F3A8CA3A24E Q35755044-769BB0C3-D24F-4F59-9EB1-A658A77A33F6 Q35921334-DE9B5476-A856-4B05-8B66-5328A7745637 Q36521130-262E30E1-3749-4234-8860-84ED8B871946 Q36589419-8570293F-E9A2-44AC-89A7-652AF85CDD63 Q36802341-EB8DC2D6-D052-474D-8B55-93553A779876 Q36929425-E092C0EE-64C8-419C-8D2F-92E91D92CF40 Q36931661-4ECB8CAB-3236-4F42-AD41-006DA255112C Q37037577-A6F688B0-5A2C-4E20-9EBC-116A79D56C59 Q37133600-4804EA20-8CFD-4494-959B-85ACCE6DEEC6 Q37264471-5B882F1B-3E9F-4B33-937B-2262564F4B4F Q37525419-3735ED7A-4B63-4866-83AD-7F990AA36D12 Q38071562-76670EF3-E2B8-4064-AA9E-C8B63454FBFD Q38121133-FBCE1923-4921-49F6-B066-9845A8F04A2E Q38235543-4C74A7EF-BEDF-4776-B249-E0EF00BEF0EB Q38730387-7A40D8A0-C737-4570-90C4-835BE074A32D Q38979293-553E4EC1-F862-41AB-8E7B-3231E523AE89 Q40050054-A4DC7A21-22B7-4BF4-BD55-E589077F5C6B Q40119877-F74F3FBE-2083-4068-9C6F-A9F81A2B2960 Q40828032-5CD6BCAA-87BE-4C8B-A394-505B20A8867E Q45340912-1E9525C2-C000-47D3-B73E-7825A0A5A9BC Q46410031-BDF68C52-9F06-4635-AB12-00200B539DC1 Q47194415-F9474A84-9B51-4981-BCD0-2EC5BC051BF4 Q47581707-9964D9F0-74A0-42BE-84DD-197D971C0FD9 Q51338194-38487C93-EFA1-4CD0-B533-B41DAD3604FE Q52564608-D3C42E99-F5C3-4D2F-B27B-C70BBB4F8D7E Q53663111-90C29F71-BBD1-422E-AF2B-B9BCC8E9BF36 Q55405985-6EA50703-5679-4113-AD89-E6D72B43EA23 Q57175256-8A67E770-C303-4B4B-9A0E-AE91939FA96A

P2860

Vitamin D and hyperparathyroidism in obesity.

http://www.wikidata.org/entity/Q35468562

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Vitamin D and hyperparathyroidism in obesity.

@ast

Vitamin D and hyperparathyroidism in obesity.

@en

type

label

Vitamin D and hyperparathyroidism in obesity.

@ast

Vitamin D and hyperparathyroidism in obesity.

@en

prefLabel

Vitamin D and hyperparathyroidism in obesity.

@ast

Vitamin D and hyperparathyroidism in obesity.

@en

P1433

Q35468562-232BB533-5124-43CF-ACBD-3519A339F8EE

P1476

Q35468562-4DD750BD-55CE-479E-A746-9B529A979C3F

P2093

Q35468562-22D0DB97-4DE4-41A6-B61D-346CD9736B68

Q35468562-2373B5F6-A027-4EED-AED7-98054DCC0042

Q35468562-26182AD1-3A5B-44AA-9B53-AC92E8D027B0

Q35468562-6B3A5DD4-D4C9-41CD-94F0-042458892DD1

Q35468562-A680A36A-195A-415B-9BFF-EACC186612D2

Q35468562-D8C908DB-DD4A-49A1-B455-F5F2A05C5B6C

Q35468562-E1E03531-A53F-435B-A7D9-4CD6081D04BB

Q35468562-E7E4F51F-2E46-4754-BF10-E951A8FF7626

Q35468562-F91437A5-44F2-408C-B715-6C0805095828

P2860

Q35468562-1D0BAC60-F109-46F9-BF45-13C887D2C278

Q35468562-26E4EAAB-2467-43A2-A84B-02B6CC469B4B

Q35468562-26F2DDFE-C8C1-4BB0-B86C-087C927F6788

Q35468562-44FD4C92-0E66-4164-9919-93ABD7AEC7C4

Q35468562-4A3986E4-0774-4863-952C-D63170E7ABE3

Q35468562-4D0B6B0B-82BA-48A6-8062-FB8C1F7A660C

Q35468562-513E7ADD-F375-4D39-A2DC-95B17F44B075

Q35468562-565A65C7-B181-42AA-8A3E-D86D50918007

Q35468562-5C4B1CF7-5612-4CCA-87DB-F7A8A296A85F

Q35468562-665C00D7-B067-4E53-B4FE-C24EC61AAA0F

P304

Q35468562-A1B02909-DB7D-4745-83A9-268F6C4E8D22

P31

Q35468562-F85ADA51-87DC-48C2-AFBF-03CE48ED9428

P356

Q35468562-B8F796AA-D02A-4CA1-9EBE-E6620CFC73AD

P407

Q35468562-CA975AC8-5881-4659-8E17-F5E7881226DB

P433

Q35468562-D2C16FC3-0ABC-4194-A203-0CE49DF3576C

P478

Q35468562-6B3442CE-2B6D-4DC9-ADD4-5FF07C1CDAAF

P50

Q35468562-0B25E50D-9280-4CDA-8742-517F53F2FFEA

P577

Q35468562-BBCB6C19-7682-4DD1-800F-1797CA36C2B3

P698

Q35468562-95C54885-C6AA-4417-A969-769C94452296

P921

Q35468562-47BE359D-C5DE-41E2-B392-51639E4FDF3F

Q35468562-D31DD5A7-870E-4128-BA64-389361B09BB5

Q35468562-E35ABEC3-2094-42B3-B2A1-505E1AB1EFB4

P932

Q35468562-8FD7E69D-2ADD-46A5-B1B3-FFF8DCAACEAE

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Vitamin D and hyperparathyroidism in obesity.

@en

P2093

Angie D Fulford

http://www.w3.org/2001/XMLSchema#string

Brenda M Cacucci

http://www.w3.org/2001/XMLSchema#string

Christine E Gupta

http://www.w3.org/2001/XMLSchema#string

David Diaz

http://www.w3.org/2001/XMLSchema#string

Elizabeth Grethen

http://www.w3.org/2001/XMLSchema#string

Munro Peacock

http://www.w3.org/2001/XMLSchema#string

Robert V Considine

http://www.w3.org/2001/XMLSchema#string

Ronald McClintock

http://www.w3.org/2001/XMLSchema#string

RoseMarie Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

Body weight, lifestyle, dietary habits and gastroesophageal reflux disease

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis

Obesity prevalence from a European perspective: a systematic review

Vitamin D(3) in fat tissue.

The association of adiposity with parathyroid hormone in healthy older adults

Decreased bioavailability of vitamin D in obesity.

Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study.

Evidence for alteration of the vitamin D-endocrine system in obese subjects.

P304

1320-1326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2010-2202

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Susan M. Perkins

P577

2011-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21325456

http://www.w3.org/2001/XMLSchema#string

P921

hyperparathyroidism

P932

3203623

http://www.w3.org/2001/XMLSchema#string